A detailed history of Wells Fargo & Company transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 11,327 shares of YMAB stock, worth $92,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,327
Previous 11,776 3.81%
Holding current value
$92,315
Previous $142,000 4.23%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$9.95 - $15.39 $4,467 - $6,910
-449 Reduced 3.81%
11,327 $148,000
Q2 2024

Aug 13, 2024

SELL
$11.6 - $17.25 $2,772 - $4,122
-239 Reduced 1.99%
11,776 $142,000
Q1 2024

May 10, 2024

BUY
$6.57 - $18.69 $10,393 - $29,567
1,582 Added 15.16%
12,015 $195,000
Q4 2023

Feb 09, 2024

BUY
$4.88 - $7.42 $10,745 - $16,338
2,202 Added 26.75%
10,433 $71,000
Q3 2023

Nov 13, 2023

SELL
$4.86 - $7.23 $31,040 - $46,178
-6,387 Reduced 43.69%
8,231 $44,000
Q2 2023

Aug 15, 2023

BUY
$5.68 - $10.34 $42,878 - $78,056
7,549 Added 106.79%
14,618 $99,000
Q1 2023

May 12, 2023

BUY
$2.83 - $5.11 $20,005 - $36,122
7,069 New
7,069 $35,000
Q3 2022

Nov 14, 2022

SELL
$13.96 - $19.67 $3,378 - $4,760
-242 Reduced 15.79%
1,291 $18,000
Q2 2022

Aug 12, 2022

SELL
$8.22 - $15.13 $134,429 - $247,436
-16,354 Reduced 91.43%
1,533 $23,000
Q1 2022

May 16, 2022

SELL
$6.55 - $17.42 $72,560 - $192,978
-11,078 Reduced 38.25%
17,887 $212,000
Q4 2021

Feb 14, 2022

SELL
$15.51 - $29.31 $204,080 - $385,660
-13,158 Reduced 31.24%
28,965 $470,000
Q3 2021

Nov 15, 2021

BUY
$27.47 - $37.31 $701,116 - $952,263
25,523 Added 153.75%
42,123 $1.2 Million
Q2 2021

Aug 16, 2021

BUY
$25.45 - $37.64 $56,651 - $83,786
2,226 Added 15.49%
16,600 $562,000
Q1 2021

May 13, 2021

SELL
$29.16 - $51.96 $364,820 - $650,071
-12,511 Reduced 46.54%
14,374 $435,000
Q4 2020

Feb 09, 2021

BUY
$37.86 - $54.26 $396,053 - $567,613
10,461 Added 63.69%
26,885 $1.33 Million
Q3 2020

Nov 05, 2020

SELL
$35.13 - $43.62 $66,184 - $82,180
-1,884 Reduced 10.29%
16,424 $632,000
Q2 2020

Aug 13, 2020

BUY
$23.66 - $49.53 $135,335 - $283,311
5,720 Added 45.44%
18,308 $791,000
Q1 2020

May 14, 2020

BUY
$14.39 - $35.8 $181,141 - $450,650
12,588 New
12,588 $329,000

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $356M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.